Views & Analysis Early approval: ‘science-based’ Gottlieb wins over sceptics After just seven months, Scott Gottlieb has stamped his own imprint on the FDA and, so far, has confounded fears he would be unduly influenced by President Trump or the pharma industry.
News PEAR raises $50m to develop digital therapeutics business PEAR Therapeutics has raised $50m in a new financing round to fund development of its prescription digital therapeutics business.
News FDA approves diabetic foot ulcer shock wave device The US regulator has approved the first ever shock wave wound healing device, for use in patients with diabetic foot ulcers.
US Sanofi turns the tables on Lilly with biosimilar fast-acting... Big-selling Humalog facing cut price competition
News Is J&J approaching the end of its talc litigation hangover? Johnson & Johnson has made a $5.5bn bid to finally bring more than 15 years of litigation over the safety of its talcum powder products to a close.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
